Mathus-Vliegen, E M H <br/><br/>
Lipase inhibition by orlistat: effects on gall-bladder kinetics and cholecystokinin release in obesity.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Mar 2004 
 - 601-11 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Randomized Controlled Trial 
<br/><br/><label>ISSN: </label>0269-2813 
<br/><br/><label>Standard No.: </label>10.1046/j.1365-2036.2004.01812.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Anti-Obesity Agents--therapeutic use<br/>Body Weight<br/>Cholecystokinin--metabolism<br/>Female<br/>Gallbladder--metabolism<br/>Humans<br/>Lactones--therapeutic use<br/>Lipase--antagonists & inhibitors<br/>Male<br/>Middle Aged<br/>Obesity--drug therapy<br/>Orlistat<br/>Weight Loss